These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30825248)

  • 21. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.
    Wu G; Liu B; Zhang Y; Li J; Arzumanyan A; Clayton MM; Schinazi RF; Wang Z; Goldmann S; Ren Q; Zhang F; Feitelson MA
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5344-54. PubMed ID: 23959305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
    Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
    Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
    Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of (1
    Wang C; Pei Y; Wang L; Li S; Jiang C; Tan X; Dong Y; Xiang Y; Ma Y; Liu G
    J Med Chem; 2020 Jun; 63(11):6066-6089. PubMed ID: 32421339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV).
    Vandyck K; Rombouts G; Stoops B; Tahri A; Vos A; Verschueren W; Wu Y; Yang J; Hou F; Huang B; Vergauwen K; Dehertogh P; Berke JM; Raboisson P
    J Med Chem; 2018 Jul; 61(14):6247-6260. PubMed ID: 29906396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D-QSAR and molecular dynamics.
    Tu J; Li JJ; Shan ZJ; Zhai HL
    Antiviral Res; 2017 Jan; 137():151-164. PubMed ID: 27908829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
    Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
    ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4.
    Ren Q; Liu X; Yan G; Nie B; Zou Z; Li J; Chen Y; Wei Y; Huang J; Luo Z; Gu B; Goldmann S; Zhang J; Zhang Y
    J Med Chem; 2018 Feb; 61(3):1355-1374. PubMed ID: 29381358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Arylthio-5-iodo pyrimidine derivatives as non-nucleoside HBV polymerase inhibitors.
    Wang J; Zhang L; Zhao J; Zhang Y; Liu Q; Tian C; Zhang Z; Liu J; Wang X
    Bioorg Med Chem; 2018 May; 26(8):1573-1578. PubMed ID: 29459146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents.
    Chen H; Ma YB; Huang XY; Geng CA; Zhao Y; Wang LJ; Guo RH; Liang WJ; Zhang XM; Chen JJ
    Bioorg Med Chem Lett; 2014 May; 24(10):2353-9. PubMed ID: 24731274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents.
    Qiu J; Zhou Q; Zhang Y; Guan M; Li X; Zou Y; Huang X; Zhao Y; Chen W; Gu X
    Eur J Med Chem; 2020 Nov; 205():112581. PubMed ID: 32791397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors.
    Qiu Z; Lin X; Zhou M; Liu Y; Zhu W; Chen W; Zhang W; Guo L; Liu H; Wu G; Huang M; Jiang M; Xu Z; Zhou Z; Qin N; Ren S; Qiu H; Zhong S; Zhang Y; Zhang Y; Wu X; Shi L; Shen F; Mao Y; Zhou X; Yang W; Wu JZ; Yang G; Mayweg AV; Shen HC; Tang G
    J Med Chem; 2016 Aug; 59(16):7651-66. PubMed ID: 27458651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis, and Bioactive Screen In Vitro of Cyclohexyl (
    Cui X; Zhou M; Tan J; Wei Z; Wei W; Luo P; Lin C
    Molecules; 2019 May; 24(11):. PubMed ID: 31151219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.
    Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G
    Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors.
    Liu L; Wang M; Li C; Han X; Xie Y; Feng K; Zhang L; Chen Y; Jia H
    Bioorg Chem; 2022 Nov; 128():106052. PubMed ID: 35921789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor.
    Xiong H; Foulk M; Aschenbrenner L; Fan J; Tiong-Yip CL; Johnson KD; Moustakas D; Fleming PR; Brown DG; Zhang M; Ferguson D; Wu D; Yu Q
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6789-93. PubMed ID: 24211022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents.
    Iyer RP; Jin Y; Roland A; Morrey JD; Mounir S; Korba B
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2199-205. PubMed ID: 15155222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors.
    Geng CA; Huang XY; Ma YB; Zhang XM; Chen JJ
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1568-71. PubMed ID: 25737009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.